Clinical trial • Phase III • Respiratory
Clinical trial in Healthy volunteers
Phase III trial for Healthy volunteers. 22 participants.
Overview
- Trial Therapeutic Area
- Respiratory
- Trial Disease
- Healthy volunteers
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 07-10-2024
- First CTIS Authorization Date
- 11-12-2024
Trial design
Phase III trial across 1 site in Austria.
- Target Sample Size
- 22
Eligibility
Recruits 22 Vulnerable population not selected (isVulnerablePopulationSelected = false). No additional consent/assent information available in the record..
- Vulnerable Population
- Vulnerable population not selected (isVulnerablePopulationSelected = false). No additional consent/assent information available in the record.
Recruitment
- Planned Sample Size
- 22
- Recruitment Window Months
- 36
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 22
Austria
- Earliest CTIS Part Ii Submission Date
- 21-10-2024
- Latest Decision Or Authorization Date
- 11-12-2024
- Processing Time Days
- 51
- Number Of Sites
- 1
- Number Of Participants
- 22
Sites
- Site Name
- Medical University Of Vienna
- Department Name
- Department of Clinical Pharmacology
- Principal Investigator Name
- Bernd Jilma
- Principal Investigator Email
- Bernd.Jilma@meduniwien.ac.at
- Contact Person Name
- Bernd Jilma
- Contact Person Email
- Bernd.Jilma@meduniwien.ac.at
- Number Of Participants
- 22
Sponsor
Primary sponsor
- Full Name
- Medical University Of Vienna
- Organisation Type
- Educational Institution
- Country Of Registered Address
- Austria
Related trials
Other published trials that may interest you.